PRESS RELEASE published on 01/22/2024 at 08:30, 2 years 6 months ago Abivax: Perspectives stratégiques d’Abivax pour 2024 et principales étapes au cours des 12 prochains mois Abivax annonce ses perspectives stratégiques pour 2024 et les principales étapes des 12 prochains mois, y compris la publication des premiers résultats des essais d'induction du programme pivot ABTECT de phase 3 Abivax Obefazimod Stratégique Perspectives Étapes Clés
PRESS RELEASE published on 01/22/2024 at 08:00, 2 years 6 months ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc announced the purchase of 105,000 of its ordinary shares on Euronext Dublin and the London Stock Exchange, as part of its share buyback program. The repurchased shares will be cancelled, and the company's total number of ordinary shares after settlement and cancellation will be 653,285,633. The detailed breakdown of individual trades made as part of the share buyback program is also provided in the announcement. London Stock Exchange Ordinary Shares Share Buyback Program Cairn Homes Plc Euronext Dublin
PRESS RELEASE published on 01/22/2024 at 08:00, 2 years 6 months ago Custodian Property Income REIT plc: Custodian Property Income REIT sells industrial unit at 9.5% premium to valuation Custodian Property Income REIT plc (CREI) announces the sale of an industrial unit in Milton Keynes at a 9.5% premium to valuation, representing a significant profit for shareholders. The sale proceeds will be used to reduce the company's existing debt facility and fund future portfolio improvements. Real Estate Investment Trust Custodian Property Income REIT Plc Industrial Unit Sale Premium To Valuation Portfolio Improvements
PRESS RELEASE published on 01/22/2024 at 08:00, 2 years 6 months ago Update on the Scheme and Resignation of Directors Arix Bioscience PLC provides an update on the recommended all-share acquisition of Arix's assets by RTW Biotech Opportunities Ltd, including the resignation of directors Maureen O'Connell and Isaac Kohlberg. The Scheme's condition related to the Share Purchase has been satisfied, and Arix expects to publish the Shareholder circular later this week. Arix Bioscience PLC RTW Biotech Opportunities Ltd All-share Acquisition Resignation Of Directors Scheme Update
PRESS RELEASE published on 01/22/2024 at 08:00, 2 years 6 months ago Nordea Bank Abp: Repurchase of own shares on 19.01.2024 Nordea Bank Abp has completed the repurchase of its own shares on 19.01.2024 as part of a share buy-back program. The transactions were executed in public trading and in accordance with relevant regulations. After the disclosed transactions, Nordea holds treasury shares for capital optimisation and remuneration purposes. For further information, investors and media can contact the provided representatives. Investor Relations Treasury Shares Nordea Bank Abp Share Buy-back Program Stock Exchange
PRESS RELEASE published on 01/22/2024 at 07:34, 2 years 6 months ago Appointment of Vulcan Group Chief Financial Officer Vulcan Energy Resources Limited announces the appointment of Ms Felicity Gooding as the Group Chief Financial Officer, bringing over 20 years of extensive global CFO experience to the company. Her expertise in capital markets and project financing will be crucial in the financing of Vulcan's Zero Carbon Lithium™ Project. This strategic appointment reflects the company's growth and development stage. Additionally, Mr Robert Ierace will step down from his role as CFO-Australia. Vulcan Energy Resources Limited aims to decarbonize lithium production and contribute to the European EV supply chain with its Zero Carbon Lithium™ Project. CFO Appointment Vulcan Energy Resources Limited Felicity Gooding Zero Carbon Lithium™ Project European EV Supply Chain
PRESS RELEASE published on 01/22/2024 at 07:30, 2 years 6 months ago Evotec SE: Invitation to Conference Call Evotec SE is going to hold a conference call to provide a statement and a business update on January 22, 2024, featuring the Chairwoman of Evotec's Supervisory Board and Evotec's CEO. The call will cover the Company's commitment to compliance with Corporate Governance standards and transparent communication, as well as the execution of its existing strategy and recent market developments. For more details, including webcast access and conference call registration, please visit the provided links. Conference Call Business Update Evotec SE Corporate Governance Market Developments
PRESS RELEASE published on 01/22/2024 at 07:15, 2 years 6 months ago Hypoport SE: volume of mortgage finance transactions continues to rise Hypoport SE announces an increase in the volume of mortgage finance transactions on Europace in the fourth quarter of 2023. The company reports growth in the mortgage finance market and positive outlook for 2024, expecting further market normalization and growth. Ronald Slabke, Chief Executive Officer, emphasizes the impact of stable interest rates and property value trends on the mortgage market. Hypoport SE Mortgage Finance Transactions Europace Market Normalization Property Value Trends
PRESS RELEASE published on 01/22/2024 at 07:00, 2 years 6 months ago NET ASSET VALUE OF REINET FUND S.C.A., F.I.S. AS AT 31 DECEMBER 2023 Reinet Fund S.C.A., F.I.S., a wholly-owned subsidiary of Reinet Investments S.C.A., has announced the net asset value (NAV) per share as at 31 December 2023. The NAV amounted to € 33.47 based on 171.3 million shares and reflected an increase of € 118 million from the previous quarter. The consolidated balance sheet of Reinet Investments S.C.A. will reflect other parent company assets and liabilities. Reinet Investments S.C.A. is a partnership limited by shares incorporated in the Grand Duchy of Luxembourg with its ordinary shares listed on the Luxembourg Stock Exchange, Euronext Amsterdam, and the Johannesburg Stock Exchange. The NAV of Reinet Fund is a substantial element of the consolidated balance sheet of Reinet Investments S.C.A. at 31 December 2023. Net Asset Value Reinet Investments S.C.A. Reinet Fund S.C.A. F.I.S. NAV Per Share Consolidated Balance Sheet
PRESS RELEASE published on 01/22/2024 at 06:45, 2 years 6 months ago HBM Healthcare Investments publishes Quarterly Report as at 31 December 2023 with key figures for the first nine months of the 2023/2024 financial year HBM Healthcare Investments AG has released their Quarterly Report for the first nine months of the 2023/2024 financial year, revealing a loss of CHF 87 million for the quarter ending on December 31, 2023. The report also details the impact of unfavourable currency developments and market indices on the company's performance, as well as the developments in the portfolio of public and private companies. The outlook section discusses recent industry developments and hints at a potentially brighter market environment with persisting volatility. The full report is available on the company's website. HBM Healthcare Investments Quarterly Report Financial Year Currency Developments Market Environment
Published on 08/15/2026 at 00:15, 1 day 20 hours ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 1 day 21 hours ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:00, 1 day 21 hours ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/16/2026 at 19:40, 1 hour 7 minutes ago APIC delivers 55% EBITDA growth in the first half of 2026, reaching USD 44 million
Published on 08/16/2026 at 13:40, 7 hours 7 minutes ago Ajax says goodbye to Godts with a classy message in Paris: THE FUTURE BELONGS TO YOUNG GODTS
Published on 08/16/2026 at 09:45, 11 hours 2 minutes ago Ragnarok Zero: Global Set to Officially Launch on August 18
Published on 08/16/2026 at 06:15, 14 hours 32 minutes ago GARVEE met en avant les essentiels pour la maison et le jardin à l’approche de la transition entre la fin de l’été et le début de l’automne
Published on 08/16/2026 at 06:15, 14 hours 32 minutes ago Garvee Spotlights Home & Garden Essentials for the Late-Summer to Early-Autumn Transition
Published on 08/13/2026 at 18:00, 3 days 2 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 5 days 3 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 5 days 3 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 6 days 2 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 6 days 2 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026